NCT04760990Completed
A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.
An Open-label Observation Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.
Source: ClinicalTrials.gov · Last updated 23 Apr 2025
Brief summary (registry, in English)
This nested project of the Swiss Multiple Sclerosis Cohort (SMSC) is to assess the severity of COVID-19 and the magnitude of antibody response after infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in patients already treated or not with various immunotherapies for multiple sclerosis followed in the framework of the SMSC.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1181 (actual)
- First submitted
- 17 Feb 2021
- Start date
- 1 Feb 2021
- Primary completion date
- 15 Dec 2023
- Lead sponsor
- University Hospital, Basel, Switzerland
- Diseases
- Multiple sclerosis
- NCT number
- NCT04760990
What you commit to
- Study type: Observational
- Participants enrolled: 1181
- From 1 Feb 2021 to the primary completion date, 15 Dec 2023
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with Neuromyelitis optica and Radiologically Isolated Syndrome will be excluded
Other
- Existence of a documented refusal of further use of health-related personal data and/or biological material
Who the study is looking for
- all patients in the Swiss Multiple Sclerosis Cohort (SMSC)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kantonsspital Aarau Coordinator of this site? Confirm its status | Aarau | Switzerland | Unknown status |
| University Hospital Basel, Department of Neurology and Department of Biomedicine Coordinator of this site? Confirm its status | Basel | Switzerland | Unknown status |
| Inselspital Bern Coordinator of this site? Confirm its status | Bern | Switzerland | Unknown status |
| Hôpitaux Universitaires Genève Coordinator of this site? Confirm its status | Geneva | Switzerland | Unknown status |
| Lausanne University Hospital (CHUV) Coordinator of this site? Confirm its status | Lausanne | Switzerland | Unknown status |
| Ospedale Regionale di Lugano Coordinator of this site? Confirm its status | Lugano | Switzerland | Unknown status |
| Kantonsspital St. Gallen Coordinator of this site? Confirm its status | Sankt Gallen | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.